Table of Contents
- Overview
- Symptoms
- Treatment
- Prevention
- Images
Familial dysautonomia; Hereditary sensory and autonomic neuropathy - type III (HSAN III)
Treatment
Treatment may include:
- Anticonvulsant therapy if there are seizures
- Feeding in an upright position and giving textured formula to prevent
gastroesophageal reflux - Increased fluid and salt intake, caffeine, and elastic stockings to prevent low blood pressure when standing (postural hypotension)
- Medicines called antiemetics, to control vomiting
- Medicines, including liquid tears, to prevent dry eyes
- Physical therapy of the chest
- Protecting the person from injury
- Providing enough nutrition and fluids
- Surgery or
spinal fusion - Treating
aspiration pneumonia
Support Groups
Expectations (prognosis)
With advances in diagnosis and treatment, survival continues to improve. Currently, a newborn with Riley-Day has a 50% chance of reaching age 30.
Complications
The following complications occur in about 40% of patients with this condition:
- Blotching of the face and torso
- Excessive sweating of the head and torso
- High blood pressure (hypertension) and rapid heart rate (tachycardia)
Insomnia - Irritability
- Mottling of the hands and feet
- Nausea/vomiting
- Severe difficulty swallowing (
dysphagia ), drooling - Worsening of muscle tone
Calling your health care provider
Call your doctor if symptoms change or get worse. A genetic counselor can help clarify information about the condition and tell you how to contact support groups in your area.
Images
Previous Section
Review Date: 10/10/2010
Reviewed By: Linda J. Vorvick, MD, Medical Director, MEDEX Northwest Division of
Physician Assistant Studies, University of Washington School of
Medicine. Also reviewed by Kevin Berman, MD, PhD, Atlanta Center
for Dermatologic Disease, Atlanta, GA. Review provided by VeriMed
Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical
Director, A.D.A.M., Inc.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org)
